breast cancer and glp 1 drugs New study examines GLP-1 a reduction in risk https://www.goodmorningamerica.com/news/story GLP-1 Receptor Agonists in Breast

Deacon C

Glucagon-like peptide-1 receptor agonists and risk of Parkinsons disease in patients with type 2 diabetes: a population-based cohort study

Tirzepatide targets GIP and GLP-1

GLP-1/GIP medications do not: reduce central pain amplification correct nervous-system hypersensitivity treat neuropathic pain reverse joint degeneration Some patients feel better simply because weight loss improves sleep, mobility, energy, and moodnot because the medication treats fibromyalgia biology

Dyslipidemia in obesity: mechanisms and potential targets

A 2016 meta-analysis of 78 studies confirmed this result, finding that GLP-1 receptor agonists significantly lowered blood sugar levels compared to placebo